Insights - Median Technologies

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

With eyonis™ we are disrupting the management of serious diseases such as lung cancer, liver cancer, and NASH. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis™ is currently under development.

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Conferences

November 26 – 30 2023

RSNA 2023

See all conferences

Webinars

Closing the Gap: Strategies for Resolving Imaging Discrepancies in Oncology Drug Trials

See all webinars

Articles

See all articles

Median in the media

Brochures

Introducing Median Imaging Lab

Scientific publications

ASCO 2023 | e-Abstract

Multicenter Evaluation of AI-Based CT Radiomics for EGFR Mutation Prediction in NSCLC

AI-powered medical image analysis has the potential to serve as predictive biomarkers for guiding targeted therapies in the future.

Case studies

How automation can improve data consistency/value, and streamline study workflow

White papers

Understanding Novel Response Patterns of Immunotherapies

Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.

Watch: Median Technologies: eyonis™, catching the unseen